Article
Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals.
BMC research notes - 9 Jul 2012
Martinez Valrie, Ta Thi Dieu Ngan, Mokhtari Zahra, Guiguet Marguerite, Miailhes Patrick, Valantin Marc-Antoine, Charlotte Frderic, Bertheau Philippe, Molina Jean-Michel, Katlama Christine, Caumes Eric
Abstract excerpt
BACKGROUND: In HIV and hepatitis C virus (HCV) coinfected patients, the role of antiretroviral therapy (ART) on hepatic steatosis (HS) remains controversial. METHODS: HIV/HCV coinfected patients receiving ART and previously untreated for HCV who underwent a liver biopsy were included. Cumulative duration of exposure to each antiretroviral was recorded up to liver biopsy date. Logistic regression analyses...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.